Focus on the gut-liver axis
NorUDCA (24-nor-ursodeoxycholic acid) is a chemically modified bile acid that has already shown promising results in the treatment of liver…
NorUDCA (24-nor-ursodeoxycholic acid) is a chemically modified bile acid that has already shown promising results in the treatment of liver…
New research from the University of Aberdeen could lead to the development of medication for disease that affects 1 in…
Approximately half of patients with advanced liver disease have varicose veins in the oesophagus and stomach, and a more than…
Alcohol-related liver disease is among the most common causes of morbidity and mortality worldwide. Due to an incomplete understanding of…
Even after chronic hepatitis C has been cured, portal hypertension remains the major factor driving the development of complications in…
If liver tissue has to be removed due to cancer or another liver disease, the organ usually regenerates quickly, soon…
Death from alcohol-related liver disease could be prevented with early diagnosis and intervention, says new study: Patients dying of alcohol-related liver…
In a recent study, an interdisciplinary research team from MedUni Vienna showed that functional magnetic resonance imaging (fMRI) can be…
Exercise supports the treatment of non-alcoholic fatty liver disease by impacting on several metabolic pathways in the body, a new…
Diseased male livers undergo sex-change: The livers of men diagnosed with hepatic diseases change sex as part of a potential…
A University of Queensland start-up company, developing a potential new treatment for obesity-related liver disease, has secured a seed investment…
Chronic inflammatory liver disease: cell stress mechanisms identified as prognostic factor: PSC is a rare disease with a poor prognosis…
This website uses cookies.